CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 27 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $465,287 | -22.6% | 304,109 | -15.0% | 0.00% | – |
Q1 2024 | $600,793 | -5.6% | 357,615 | -2.3% | 0.00% | – |
Q4 2023 | $636,725 | -11.3% | 365,934 | -3.6% | 0.00% | – |
Q3 2023 | $717,671 | -3.8% | 379,720 | -25.1% | 0.00% | – |
Q2 2023 | $745,716 | -37.2% | 507,290 | -16.7% | 0.00% | – |
Q1 2023 | $1,187,614 | +84487.9% | 609,033 | -2.4% | 0.00% | – |
Q4 2022 | $1,404 | -99.9% | 623,871 | +0.0% | 0.00% | -100.0% |
Q3 2022 | $1,503,000 | +15.4% | 623,867 | -0.5% | 0.00% | – |
Q2 2022 | $1,302,000 | -27.2% | 627,200 | -1.1% | 0.00% | -100.0% |
Q1 2022 | $1,788,000 | -41.3% | 633,904 | -2.9% | 0.00% | 0.0% |
Q4 2021 | $3,047,000 | +62.0% | 652,561 | -6.3% | 0.00% | 0.0% |
Q3 2021 | $1,881,000 | -12.5% | 696,654 | -7.8% | 0.00% | 0.0% |
Q2 2021 | $2,149,000 | -3.9% | 755,500 | +2.4% | 0.00% | 0.0% |
Q1 2021 | $2,236,000 | -2.7% | 737,881 | -5.6% | 0.00% | 0.0% |
Q4 2020 | $2,299,000 | -10.4% | 781,891 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $2,565,000 | -7.3% | 798,954 | -3.8% | 0.00% | 0.0% |
Q2 2020 | $2,766,000 | -10.6% | 830,687 | -2.6% | 0.00% | -50.0% |
Q1 2020 | $3,095,000 | -30.2% | 852,622 | -0.9% | 0.00% | 0.0% |
Q4 2019 | $4,431,000 | -13.1% | 860,319 | +0.0% | 0.00% | 0.0% |
Q3 2019 | $5,100,000 | -7.2% | 860,088 | -0.3% | 0.00% | 0.0% |
Q2 2019 | $5,497,000 | +8.0% | 862,919 | -1.5% | 0.00% | 0.0% |
Q1 2019 | $5,091,000 | -8.2% | 876,239 | -0.5% | 0.00% | -33.3% |
Q4 2018 | $5,546,000 | +10.6% | 880,248 | +0.2% | 0.00% | +50.0% |
Q3 2018 | $5,015,000 | -6.2% | 878,348 | +0.7% | 0.00% | 0.0% |
Q2 2018 | $5,349,000 | -9.3% | 872,674 | -1.2% | 0.00% | 0.0% |
Q1 2018 | $5,899,000 | -10.5% | 883,085 | -0.6% | 0.00% | -33.3% |
Q4 2017 | $6,592,000 | +7.1% | 888,411 | +1.9% | 0.00% | 0.0% |
Q3 2017 | $6,157,000 | +0.5% | 872,087 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $6,125,000 | +2.2% | 866,283 | +0.3% | 0.00% | 0.0% |
Q1 2017 | $5,995,000 | +27.8% | 863,819 | +1.3% | 0.00% | +50.0% |
Q4 2016 | $4,691,000 | +10.1% | 852,976 | +0.3% | 0.00% | 0.0% |
Q3 2016 | $4,259,000 | +11.3% | 850,185 | -0.0% | 0.00% | 0.0% |
Q2 2016 | $3,827,000 | -0.0% | 850,507 | -0.2% | 0.00% | 0.0% |
Q1 2016 | $3,828,000 | -14.8% | 852,511 | -0.2% | 0.00% | -33.3% |
Q4 2015 | $4,491,000 | -8.6% | 853,836 | +0.2% | 0.00% | 0.0% |
Q3 2015 | $4,916,000 | -19.5% | 851,964 | -0.2% | 0.00% | -25.0% |
Q2 2015 | $6,104,000 | +8.2% | 853,647 | +0.8% | 0.00% | 0.0% |
Q1 2015 | $5,642,000 | +10.7% | 847,135 | -0.3% | 0.00% | +33.3% |
Q4 2014 | $5,098,000 | +21.6% | 849,686 | +0.1% | 0.00% | 0.0% |
Q3 2014 | $4,193,000 | +8.8% | 848,839 | -0.9% | 0.00% | 0.0% |
Q2 2014 | $3,855,000 | +16.8% | 856,581 | +16.8% | 0.00% | +50.0% |
Q1 2014 | $3,300,000 | -11.4% | 733,379 | +0.6% | 0.00% | -33.3% |
Q4 2013 | $3,725,000 | +11.7% | 729,006 | -1.0% | 0.00% | 0.0% |
Q3 2013 | $3,336,000 | -11.5% | 736,409 | -0.2% | 0.00% | -25.0% |
Q2 2013 | $3,770,000 | – | 737,694 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sterling Financial Planning, Inc. | 22,031 | $59,000 | 0.04% |
BERKSHIRE ASSET MANAGEMENT LLC/PA | 176,185 | $472,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,987 | $435,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 162,217 | $429,000 | 0.00% |
Renaissance Technologies | 664,564 | $1,781,000 | 0.00% |
Oakworth Capital, Inc. | 3,052 | $8,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 696,654 | $1,881,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 16,246 | $44,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,614 | $13,000 | 0.00% |
MORGAN STANLEY | 3,172 | $8,000 | 0.00% |